Document is current
Any future updates will be listed below
-
Authors
Kivelä, Anni
Aittasalo, Minna
Renlund-Vikström, Michelle
Heinonen, Seppo
Sarkola, Taisto
Laivuori, Hannele
Jääskeläinen, Tiina
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 23 September 2024
Accepted: 7 November 2025
First Online: 2 December 2025
Declarations
:
: The approval of the study protocol was granted (HUS/3347/2018) from the Ethics Committee of the Hospital District of Helsinki and Uusimaa in December 2018. Informed consent was required for study participation. The parents provided informed consent for their child to participate in the FINNCARE study, and the child also gave their own permission to participate. The study adhered to the Declaration of Helsinki.
: Not applicable.
: HL has also received funding for her institution (Tampere University, Finland, Tampere) for EraPerMed (Horizon 2020, Academy of Finland), honoraria from Orion corporation, and has served as the President of the Finnish Society of Obstetrics and Gynecology (non-paid). TJ has received honoraria from Orion Corporation, a consulting fee from Finnish Heart Association, served as a member of the working group for Finnish Current Care Guidelines/pre-eclampsia (non-paid), and was a member of the board 2019–2022 (unpaid) and chair 2020–2021 (paid) in The Association of Clinical and Public Health Nutritionists in Finland. TS has served as a research advisory board member in Gyllenberg foundation (non-paid).
